Pharma: Merck is building the tools for the next revolution

—·5h

The German Merck Group is taking over the US laboratory specialist Bio-Techne for ten billion euros. What makes this business so attractive – and what risks there are.

TickersUSChannelscurrencies, semiconductors, stocksCountriesgermany, europeCategoriescurrencies

Open original source ↗

Published

6/25/2026, 3:02:07 PM

Fetched

6/25/2026, 6:07:39 PM

Confidence

60 / 100

Relevance

37 / 100

Trust

—

Language